Page last updated: 2024-11-13

nxl 103

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

flopristin, linopristin drug combination: a mixture of flopristin (RPR132552A) and linopristin (RPR202698) [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID118797980
MeSH IDM0504616

Synonyms (6)

Synonym
nxl 103
xrp 2868
flopristin, linopristin drug combination
642080-29-3
flopristin - linopristin
nxl103

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"5 to 640 mg/kg/day of XRP 2868 fractionated for 3-, 6-, 12-, and 24-h dosing regimens."( Pharmacodynamics of a new streptogramin, XRP 2868, in murine thigh and lung infection models.
Andes, D; Craig, WA, 2006
)
0.33
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (57.14)29.6817
2010's3 (42.86)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (14.29%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (85.71%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]